CURA.TO
CURA.TO
CA23126M1023
CURALEAF HOLDINGS INC
Loading chart...

Company Profile

Curaleaf Holdings, Inc. engages in the retail and wholesale of cannabis products in the United States and internationally. The company operates licensed cultivation; and pharma-grade cannabis processing and manufacturing facilities. It also supplies cannabis on a wholesale basis to Australia, New Zealand, the United Kingdom and various European countries, including Germany, Italy, Poland, the Czech Republic, Switzerland, Sweden and Norway. In addition, the company operates a medical cannabis clinic and holds a pharmacy license. It serves the medical and adult-use cannabis markets through retail and wholesale channels. The company is based in Stamford, Connecticut.

Related stocks

INDV
INDV • United States
Indivior Pharmaceuticals, Inc.
35.83 USD
4.23B USD 1Y +47.3%
XERS
XERS • United States
Xeris Biopharma Holdings, Inc.
10.48 USD
1.91B USD 1Y +24.3%
LQDA
LQDA • United States
Liquidia Corporation
27.38 USD
2.45B USD 1Y +16.4%
GTII.CN
GTII.CN • United States
GreenThumb
9.58 CAD
1.47B USD 1Y -21.2%
ETON
ETON • United States
Eton Pharmaceuticals, Inc.
55.21 USD
1.58B USD 1Y +161.6%
SUPN
SUPN • United States
Supernus Pharmaceuticals, Inc.
42.67 USD
2.48B USD 1Y -12.2%
AQST
AQST • United States
Aquestive Therapeutics, Inc.
4.78 USD
599.95M USD 1Y -23.2%
AMRX
AMRX • United States
Amneal Pharmaceuticals, Inc.
19.91 USD
6.93B USD 1Y +87.5%

Key Metrics & Overview

Detailed metrics & financial data of the company

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
5Y Volatility
88.5% p.a.
Max Drawdown (5Y)
-92.8%
Sharpe Ratio (5Y)
-0.26
Beta Factor
1.60
Size Class
Mid Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Unprofitable business model: The company is currently generating net losses.
High market risk: Beta of 1.60 indicates above-average volatility compared to the broader market.
🔴 Low analyst coverage – higher uncertainty in growth estimates & projections
Elevated Short-Term Volatility: 3Y volatility (98.5%) is noticeably higher than the 5Y average (88.5%).
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (88.5% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -92.8% in the extended horizon.
ende